Jeffrey Moore

Jeff received his BSc from the University of New Brunswick. He earned his PhD at Oxford, where he elucidated the ability of viruses to overcome host defenses by producing immunosuppressive steroid hormones. He also served on the Oxford Graduate Union and LMH Executive Committee. Jeff received his MBA as a Sloan Fellow at MIT, focusing on finance, strategy and entrepreneurship.

Jeff Moore is President of MP Healthcare Venture Management (MPH), the VC firm of Mitsubishi Tanabe Pharma Corporation, and Board of Director member of Diamond Edge Ventures (DEV), the VC arm of Mitsubishi Chemical Group. Previously, Dr. Moore was a Kauffman Fellow with the early stage venture firm Research Corporation Technologies. He has held various business and scientific roles at Millennium Pharmaceuticals and Scriptgen Therapeutics. He received his DPhil from the University of Oxford, studying virus vaccines, and then did postdoctoral training in infectious disease at Harvard Medical School. Dr. Moore received his MBA as a Sloan Fellow at MIT, and his BSc in Biology from the University of New Brunswick.

A member of Class 10, Jeff served his fellowship under mentor Shaun Kirkpatrick at Research Corporation Technologies in Tucson, AZ. He is mentor to Laura Tadvalkar (Class 23).